Sign in
4

Changes in Ownership

International Stem Cell CORP Filed Acc 0001019687-12-002015

Options or other derivatives

  • CEO acquired 750,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Semechkin Andrey · CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-05-29 Grant or award : show line 1 in the form Stock Option (Right to Buy +750,000 $0.32 2022-05-29 750,000 750,000 D
Loading xslF345X03/semechkin_f4.xml…